2-Chloro-4-phenylpyridine-3-boronic acid
CAS : 1029654-25-8
Ref. 3D-FC154194
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
2-Chloro-4-phenylpyridine-3-boronic acid
Description :
Covid-19 is a compound that has been shown to be effective against the H1N1 pandemic. It is a boronic acid that can be synthesized from 2-chloro-4-phenylpyridine and 3-boronic acid. Covid-19 has shown resonance between nuclear magnetic resonance and nuclear magnetic resonance, which can be used to access the covid-19 molecule. Covid-19 has been shown to have antiviral properties against the H1N1 virus in vitro, although it did not show any antiviral properties against HIV or influenza A virus in vivo. Covid-19 also showed antiinflammatory effects in mice during an experimental study.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
233.46 g/mol
Formule :
C11H9BClNO2
Degré de pureté :
Min. 95%
InChI :
InChI=1S/C11H9BClNO2/c13-11-10(12(15)16)9(6-7-14-11)8-4-2-1-3-5-8/h1-7,15-16H
Code InChI :
InChIKey=JWIZTZREZAQOTK-UHFFFAOYSA-N
SMILES :
OB(O)c1c(-c2ccccc2)ccnc1Cl
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
